Prevention of Glucocorticoid-induced Osteoporosis

    loading  Checking for direct PDF access through Ovid



Patients taking low-dose glucocorticoids for 3 months or more are at risk for rapid bone loss. The loss may be as high as 15% in the first 3 to 6 months of treatment, and can lead to osteoporotic fractures, with an increase in morbidity and mortality. This article discusses an evidence-based approach to the prevention of glucocorticoid-induced osteoporosis.

Related Topics

    loading  Loading Related Articles